There's never a dull week on Wall Street. Let's go over some of the news that will shape the week to come.
The new trading week kicks off with Peregrine Pharmaceuticals (NASDAQ: PPHM) posting its latest quarterly results.
The biotech has been one of the market's most volatile stocks. It got crushed in September, when it revealed that initially upbeat data from a clinical trial for its non-small-cell lung cancer drug was mishandled and inaccurate.
Peregrine bounced back last month, though naturally it's expected to post another quarterly loss on Monday.
Geospace Technologies (NASDAQ:GEOS) reports on Tuesday.The maker of gear used by the oil and gas industry in the acquisition and processing of seismic data is expected to post a profit of $0.66 a share in its fiscal fourth quarter, more than doubling the $0.28 it delivered a year earlier.
Joy Global (NYSE: JOY) and Avanir Pharmaceuticals (NASDAQ: AVNR) report on Wednesday. The two companies have little in common. Joy Global sells mining equipment. Avanir is a biotech focusing on the treatment of central nervous system disorders. However, both companies are expected to post bottom-line improvements since the same period a year earlier.
Southcross Energy Partners (NYSE: SXE) streams in on Thursday. The owner of natural-gas pipelines and a player in the liquefied-natural-gas market just went public last month at $20. It will now be posting its first quarterly report as a public company.
The final trading day of the week will be quiet on the earnings front, but that will only give traders time to head out to the local multiplex to catch The Hobbit: An Unexpected Journey. Peter Jackson is back at the helm after his globally successful Lord of the Rings trilogy.
Check that calendar
If you like to stay on top of what happens next -- and I'm guessing you do, because you're reading this article -- how about checking out a new report identifying the one energy stock that you must own before 2014? Yes, 2014. It's a free report, but only for a limited time, so click here to check it out now.